UPDATED May 07, 2024
Discover large cap French Pharmaceuticals & Biotech companies that are on the CAC. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SAN | €91.88 | -1.3% | -8.9% | €114.7b | €108.06 | PE25.3x | E16.6% | 4.1% | ||
DIM | €208.20 | 2.6% | -15.3% | €20.3b | €251.33 | PE79.5x | E23.3% | 0.3% | ||
ERF | €56.72 | -1.5% | -9.0% | €10.9b | €60.88 | PE42.6x | E20.3% | 0.9% | ||
IPN | €115.20 | 1.0% | 3.7% | €9.5b | €125.53 | PE15.4x | E6.3% | 1.0% | ||
VIRP | €348.50 | 0.4% | 18.3% | €2.9b | €368.00 | PE24x | E11.2% | 0.4% | ||
VETO | €95.30 | 1.1% | 2.5% | €1.1b | €105.67 | PE20.3x | E4.8% | 0.9% | ||
ABVX | €14.02 | -5.0% | -6.9% | €882.1m | €37.59 | PS196.3x | E9.8% | n/a | ||
BOI | €34.30 | 0% | -13.2% | €595.5m | €39.60 | PE12.5x | E-0.3% | 3.2% | ||
VLA | €3.42 | 1.1% | -37.9% | €474.1m | €8.95 | PS3.1x | E57.0% | n/a | ||
MEDCL | €14.84 | 3.3% | 77.7% | €426.6m | €17.15 | PS30.2x | E67.8% | n/a | ||
NANO | €6.22 | 14.1% | 23.3% | €292.8m | €10.60 | PS8.1x | E6.5% | n/a | ||
EAPI | €3.08 | 4.3% | -71.0% | €291.9m | €4.72 | PB0.3x | E85.2% | n/a | ||
ALCLS | €2.75 | 12.7% | 60.5% | €197.0m | n/a | PS23x | E56.2% | n/a | ||
ALSEN | €0.70 | 0.3% | 159.3% | €192.9m | €2.38 | PS34.7x | E42.8% | n/a | ||
IPH | €2.29 | 3.9% | -16.4% | €185.1m | €6.27 | PS3x | E33.0% | n/a | ||
AELIS | €13.10 | 0.8% | -6.8% | €172.0m | €20.67 | PS13.9x | E-43.4% | n/a | ||
IVA | €3.30 | 11.5% | 38.7% | €171.6m | €13.83 | PS7.4x | E17.6% | n/a | ||
GNFT | €3.28 | 2.5% | -13.8% | €163.1m | €9.38 | PS4.7x | E54.7% | n/a | ||
ALERS | €14.48 | 0.6% | -15.4% | €148.1m | €30.00 | PE30.8x | E36.3% | n/a | ||
OSE | €6.48 | 14.9% | 73.0% | €139.8m | €7.15 | PS62.8x | E92.9% | n/a | ||
TNG | €1.32 | 6.5% | -25.0% | €132.7m | €3.50 | PS16.8x | E-26.1% | n/a | ||
ADOC | €8.42 | 0.7% | 121.9% | €120.3m | €9.70 | PS19.9x | E104.5% | n/a | ||
DBV | €1.22 | -1.8% | -59.2% | €117.6m | €4.78 | PS8x | E53.3% | n/a | ||
PCA | €8.00 | 0% | 11.1% | €109.9m | n/a | PE12.5x | n/a | 0% |